REPEALED.  L 1972, c 10, §7.




  §§329-14 and 329-22 are renumbered §§329-39 and 329-44, respectively, and assigned to the new chapter 329, Uniform Controlled Substances Act.  L 1972, c 10, §§7, 8.





        Part I.  General Provisions


    329-1 Definitions

    329-2 Hawaii advisory commission on drug abuse and

          controlled substances; number; appointment

    329-3 Annual report

    329-4 Duties of the Hawaii advisory commission on drug

          abuse and controlled substances


        Part II.  Standards and Schedules

   329-11 Authority to schedule controlled substances

   329-12 Nomenclature

   329-13 Schedule I tests

   329-14 Schedule I

   329-15 Schedule II tests

   329-16 Schedule II

   329-17 Schedule III tests

   329-18 Schedule III

   329-19 Schedule IV tests

   329-20 Schedule IV

   329-21 Schedule V tests

   329-22 Schedule V

   329-23 Republishing and distribution of schedules


        Part III.  Regulation of Manufacture, Distribution,

                   Prescription, and Dispensing of Controlled


   329-31 Rules

 329-31.5 Clinics

   329-32 Registration requirements

   329-33 Registration

   329-34 Revocation and suspension of registration

   329-35 Order to show cause

   329-36 Records of registrants

   329-37 Filing requirements

 329-37.5 Mandatory reporting

   329-38 Prescriptions

329-38.2, 38.5 Repealed

   329-39 Labels

 329-39.5 Opioid warning label

   329-40 Methadone treatment programs


        Part IV.  Offenses and Penalties

   329-41 Prohibited acts B--penalties

   329-42 Prohibited acts C--penalties

   329-43 Penalties under other laws

 329-43.5 Prohibited acts related to drug paraphernalia

 329-43.6 Overdose prevention; limited immunity

   329-44 Notice of conviction to be sent to licensing board,

          department of commerce and consumer affairs

   329-45 Repealed

   329-46 Prohibited acts related to visits to more than one

          practitioner to obtain controlled substance


   329-49 Administrative penalties

   329-50 Injunctive relief


        Part V.  Enforcement and Administrative Provisions

   329-51 Powers of enforcement personnel

   329-52 Administrative inspections

   329-53 Injunctions

   329-54 Cooperative arrangements and confidentiality

   329-55 Forfeitures

   329-56 Burden of proof; liabilities

   329-57 Judicial review

   329-58 Education and research

   329-59 Controlled substance registration revolving fund;



        Part VI.  Regulated Chemicals for the Manufacture of

                  Controlled Substances

   329-61 Substances subject to reporting

   329-62 Proper identification

   329-63 Person required to keep records and file reports

   329-64 Exceptions

   329-65 Penalty

   329-66 Theft, loss, and discrepancy reports

   329-67 Permit for conduct of business; applications; forms;

          fees; renewal; violations

   329-68 Protection of records; divulging confidential

          information prohibited; penalties

   329-69 Subpoena powers

   329-70 Forfeiture

   329-71 Requirements when selling specific chemicals

   329-72 Rules

   329-73 Repealed

   329-74 Unlawful transport of pseudoephedrine

   329-75 Sales of products, mixtures, or preparations

          containing pseudoephedrine; reporting requirement

          for wholesalers


        Part VII.  Precursors to Controlled Substances--Repealed

   329-81 to 91 Repealed


        Part VIII.  Electronic Prescription Accountability


  329-101 Reporting of dispensation of controlled substances;

          electronic prescription accountability system;

          requirements; penalty

  329-102 Central repository

  329-103 Designated state agency

  329-104 Confidentiality of information; disclosure of



        Part IX.  Medical Use of Cannabis

  329-121 Definitions

  329-122 Medical use of cannabis; conditions of use

  329-123 Registration requirements; qualifying patients;

          primary caregivers

329-123.5 Registration requirements; qualifying out-of-state

          patient; caregiver of a qualifying out-of-state


  329-124 Insurance not applicable

  329-125 Protections afforded to a qualifying patient, primary

          caregiver, qualifying out-of-state patient, or

          caregiver of a qualifying out-of-state patient

329-125.5 Medical cannabis patient and caregiver protections

329-125.6 Protections afforded to an owner or qualified

          employee of a licensed medical cannabis dispensary

  329-126 Protections afforded to a treating physician or

          advanced practice registered nurse

  329-127 Protection of cannabis and other seized property

  329-128 Fraudulent misrepresentation; penalty

  329-129 Prohibited acts; flammable solvents

  329-130 Authorized sources of medical cannabis

  329-131 Prescription and pharmacy requirements not applicable


Cross References


  Drug dealer liability, see chapter 663E.

  Medical cannabis; economic and other data; collection, see §201-13.9.

  Medical cannabis testing and research programs, see §304A-1865.

  Money laundering, see chapter 708A.


Law Journals and Reviews


  Regression by Progression:  Unleveling the Classroom Playing Field Through Cosmetic Neurology.  33 UH L. Rev. 193 (2010).

  The "Grande Iced Nonfat Chai with a Shot of Espresso" Problem:  Dealing with Designer Drugs in the Wake of McFadden v. United States.  39 UH L. Rev. 265 (2016).


Case Notes


  Hawaii county ordinance that established cannabis offenses as the lowest law enforcement priority in the county conflicted with, and was therefore preempted by, this chapter and other state laws governing the investigation and prosecution of alleged violations of the Hawaii Penal Code concerning the adult personal use of cannabis.  135 H. 411, 353 P.3d 953 (2015).

  This chapter preempted a Hawaii county ordinance that made the enforcement of marijuana laws the lowest enforcement priority in the county, because the ordinance covered the adult personal use of cannabis, which was the same subject matter that the legislature intended to govern under this chapter.  132 H. 511 (App.), 323 P.3d 155 (2014).